Title
| Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer |
Related title | Preclinical investigations and first-in-human application of 152Tb-PSMA-617 for PET/CT imaging of prostate cancer
|
Author(s)
|
Müller, Cristina (PSI, Villigen) ; Singh, Aviral (Unlisted, DE ; Unlisted, NL) ; Umbricht, Christoph A (PSI, Villigen) ; Kulkarni, Harshad R (Unlisted, DE) ; Johnston, Karl (CERN) ; Benešová, Martina (PSI, Villigen) ; Senftleben, Stefan (Unlisted, DE) ; Müller, Dirk (Unlisted, DE) ; Vermeulen, Christiaan (PSI, Villigen) ; Schibli, Roger (ETH, Zurich (main) ; PSI, Villigen) ; Köster, Ulli (Laue-Langevin Inst.) ; van der Meulen, Nicholas P (PSI, Villigen) ; Baum, Richard P (Unlisted, DE) Visualizza tutti i 13 autori |
Publication
| 2019 |
Number of pages
| 10 |
In:
| EJNMMI Res. 9 (2019) 68 |
DOI
| 10.1186/s13550-019-0538-1
|
Subject category
| Other |
Abstract
| The results of this study demonstrate the successful preparation and preclinical testing of 152Tb-PSMA-617 and its first application in a patient with mCRPC. This work could pave the way towards clinical application of other Tb radionuclides in the near future, most importantly 161Tb, which has promising decay characteristics for an effective treatment of mCRPC patients. |
Copyright/License
| publication: © 2019-2025 The authors (License: CC-BY.4.0) |